An Apoptotic Body‐Mimetic Nanoagonist for Synergistic Diabetic Wound Immunotherapy
Diabetic skin injury (DSI), which are challenging to heal, contribute to global economic losses exceeding US$ 250 billion annually. The impaired healing process is primarily driven by severe local inflammation, excessive oxidative stress, and restricted angiogenesis, with dysfunctional macrophage polarization being a c...